Gastrointestinal-activated Amifostine Ameliorates Morbid Toxicity from Stereotactic Radiation in a Murine Model

Authors :: W.K. Chan
P.L. Lorenzi
Amit Deorukhkar
Kathryn A. Mason
Aaron J. Grossberg
J.M. Tour
Jessica M. Molkentine
Tara N. Fujimoto
Robert Dantzer
Cullen M. Taniguchi
T.D. Horvath
Source :: International Journal of Radiation Oncology*Biology*Physics. 102:S76
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Cancer Research
Radiation
Oncology
Stereotactic radiation
business.industry
Murine model
Toxicity
Cancer research
Medicine
Radiology, Nuclear Medicine and imaging
Amifostine
business
medicine.drug

Full Text Access

Tools